Literature DB >> 19401538

Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets.

Catherine S Adamson1, Eric O Freed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19401538      PMCID： PMC2861802          DOI： 10.1124/mi.9.2.5

Source DB:  PubMed          Journal:  Mol Interv        ISSN： 1534-0384


× No keyword cloud information.
  44 in total

1.  Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein.

Authors:  Owen Pornillos; Steven L Alam; Darrell R Davis; Wesley I Sundquist
Journal:  Nat Struct Biol       Date:  2002-11

Review 2.  Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1.

Authors:  Ken Fujii; James H Hurley; Eric O Freed
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

Review 3.  Development of protease inhibitors and the fight with drug-resistant HIV-1 variants.

Authors:  Hiroaki Mitsuya; Kenji Maeda; Debananda Das; Arun K Ghosh
Journal:  Adv Pharmacol       Date:  2008

Review 4.  HIV entry inhibitors.

Authors:  José A Esté; Amalio Telenti
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

5.  An essential role for LEDGF/p75 in HIV integration.

Authors:  Manuel Llano; Dyana T Saenz; Anne Meehan; Phonphimon Wongthida; Mary Peretz; William H Walker; Wulin Teo; Eric M Poeschla
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

Review 6.  Maturation inhibitors: a new therapeutic class targets the virus structure.

Authors:  Karl Salzwedel; David E Martin; Michael Sakalian
Journal:  AIDS Rev       Date:  2007 Jul-Sep       Impact factor: 2.500

7.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

8.  Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.

Authors:  Brian N Kelly; Sampson Kyere; Isaac Kinde; Chun Tang; Bruce R Howard; Howard Robinson; Wesley I Sundquist; Michael F Summers; Christopher P Hill
Journal:  J Mol Biol       Date:  2007-08-15       Impact factor: 5.469

9.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

10.  Molecular characterization of feline immunodeficiency virus budding.

Authors:  Benjamin G Luttge; Miranda Shehu-Xhilaga; Dimiter G Demirov; Catherine S Adamson; Ferri Soheilian; Kunio Nagashima; Andrew G Stephen; Robert J Fisher; Eric O Freed
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103
View more
  8 in total

1.  Trehalose Inhibits Human Immunodeficiency Virus Type 1 Infection in Primary Human Macrophages and CD4+ T Lymphocytes through Two Distinct Mechanisms.

Authors:  Pratima Rawat; Simson Hon; Carmen Teodorof-Diedrich; Stephen A Spector
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  The path well traveled: using mammalian retroviruses to guide research on XMRV.

Authors:  KyeongEun Lee; Kathryn S Jones
Journal:  Mol Interv       Date:  2010-02

Review 3.  New insights into HIV assembly and trafficking.

Authors:  Muthukumar Balasubramaniam; Eric O Freed
Journal:  Physiology (Bethesda)       Date:  2011-08

4.  In-solution enrichment identifies peptide inhibitors of protein-protein interactions.

Authors:  Fayçal Touti; Zachary P Gates; Anupam Bandyopadhyay; Guillaume Lautrette; Bradley L Pentelute
Journal:  Nat Chem Biol       Date:  2019-03-18       Impact factor: 15.040

5.  Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase.

Authors:  Tomoaki Sasaki; Zachary T K Gannam; Shalley N Kudalkar; Kathleen M Frey; Won-Gil Lee; Krasimir A Spasov; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2019-06-26       Impact factor: 2.823

Review 6.  Mechanisms of HIV-1 Control.

Authors:  Mary Soliman; Geetha Srikrishna; Ashwin Balagopal
Journal:  Curr HIV/AIDS Rep       Date:  2017-06       Impact factor: 5.071

Review 7.  Retroviral RNase H: Structure, mechanism, and inhibition.

Authors:  Tatiana V Ilina; Teresa Brosenitsch; Nicolas Sluis-Cremer; Rieko Ishima
Journal:  Enzymes       Date:  2021-09-24

8.  Structure-based evaluation of C5 derivatives in the catechol diether series targeting HIV-1 reverse transcriptase.

Authors:  Kathleen M Frey; William T Gray; Krasimir A Spasov; Mariela Bollini; Ricardo Gallardo-Macias; William L Jorgensen; Karen S Anderson
Journal:  Chem Biol Drug Des       Date:  2014-03-14       Impact factor: 2.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.